| Andrea J Bartels, RPH | |
|
2020 Coffee Rd Ste C2, Modesto, CA 95355-2407 | |
| (209) 522-3367 | |
| (209) 522-3375 |
| Full Name | Andrea J Bartels |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2020 Coffee Rd Ste C2, Modesto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063655652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 61357 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea J Bartels, RPH 2020 Coffee Rd Ste C2, Modesto, CA 95355-2407 Ph: (209) 522-3367 | Andrea J Bartels, RPH 2020 Coffee Rd Ste C2, Modesto, CA 95355-2407 Ph: (209) 522-3367 |
News Archive
Two previously unassociated proteins known to be overly active in a variety of cancers bind together to ignite and sustain malignant brain tumors, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports this week in the journal Cancer Cell.
Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.
Researchers from this international study found that patients with chronic hepatitis B virus (HBV) infection who received at least 3 years of cumulative entecavir (antiviral) therapy achieved substantial histologic improvement and regression of fibrosis or cirrhosis. Full details of the study appear in the September issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).
Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.
A new study by Robert Stahelin, an adjunct associate professor of chemistry and biochemistry at the University of Notre Dame and an associate professor at the Indiana University School of Medicine-South Bend, as well as a member of Notre Dame's Eck Institute for Global Health, investigates how the most abundant protein that composes the Ebola virus, VP 40, mediates replication of a new viral particle.
› Verified 7 days ago
Dr. Sujeev Vhan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3405 Mchenry Ave, T-0273, Modesto, CA 95350 Phone: 209-523-6210 | |
Cindie Masui, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1032 Oakdale Rd, Modesto, CA 95355 Phone: 209-577-6060 | |
Mrs. Truc Thanh Vo, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1101 Mchenry Ave, Modesto, CA 95350 Phone: 209-577-8695 | |
Grace Cho, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2900 Standiford Ave, Modesto, CA 95350 Phone: 209-522-1093 | |
Kenia Yulissa Medina Moreno, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1441 Florida Ave, Modesto, CA 95350 Phone: 209-576-3622 | |
Dr. Stephanie Tovar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 Coffee Rd, Modesto, CA 95355 Phone: 209-526-4500 | |
Ashley Avila, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3801 Pelandale Ave, Modesto, CA 95356 Phone: 209-342-4902 |